VioOne HIV Profile Supplemental Assay

NACompletedINTERVENTIONAL
Enrollment

757

Participants

Timeline

Start Date

January 3, 2018

Primary Completion Date

April 11, 2018

Study Completion Date

April 11, 2018

Conditions
HIV Infections
Interventions
DEVICE

VioOne HIV Profile Supplemental Assay

The VioOne™ HIV Profile™ Supplemental Assay is an enzyme-linked immunosorbent assay (ELISA) for confirmation and differentiation of individual antibodies directed to various gene products of Human Immunodeficiency Virus Type 1 (HIV-1 Group M \& Group O) and Type 2 (HIV-2) in human serum or plasma. The HIV Profile™ is intended as an aid in the diagnosis of infection with HIV-1 and/or HIV-2.

Trial Locations (1)

27712

Avioq Inc, Research Triangle Park

All Listed Sponsors
collaborator

Clinical Reference Laboratory

INDUSTRY

collaborator

Duke Clinical Research Institute

OTHER

collaborator

University of North Carolina

OTHER

lead

Avioq, Inc.

INDUSTRY